XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) Stock Analysis

XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) is a publicly traded Healthcare sector company. As of May 21, 2026, XTLB trades at $2.57 with a market cap of $6.39M and a P/E ratio of 0.00. XTLB moved -2.57% today. Year to date, XTLB is +1.34%; over the trailing twelve months it is -43.64%. Its 52-week range spans $2.12 to $10.28. Rallies surfaces XTLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest XTLB stock research?

XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. XTLB moved -2.57% today.

XTLB Key Metrics

Key financial metrics for XTLB
MetricValue
Price$2.57
Market Cap$6.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$10.28
52-Week Low$2.12
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest XTLB News

Recent XTLB Insider Trades

  • EDELMAN JOSEPH sold 9.60M (~$1.47M) on Nov 19, 2008.
  • EDELMAN JOSEPH sold 24.68M (~$3.48M) on Nov 18, 2008.
  • EDELMAN JOSEPH sold 2.70M (~$412.02K) on Nov 18, 2008.

XTLB Analyst Consensus

XTLB analyst coverage data. Average price target: $0.00.

Common questions about XTLB

What can I research for XTLB on Rallies?
XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. XTLB moved -2.57% today.
Does Rallies show live market data for XTLB?
Rallies combines live market context with ticker research for XTLB, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
XTLB

XTLB